Emergent BioSolutions Reports Third Quarter 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 5.95 +0.05 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.90 | 52 Week High | $44.38 | |||
| Open | $5.91 | 52 Week Low | $24.47 | |||
| Day High | $6.00 | P/E | 297.50 | |||
| Day Low | $5.80 | EPS | $0.02 | |||
| Volume | 95,526 | |||||
